Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
BioNano Genomics (BNGO) Stock Price & Analysis
8,711 Followers
BNGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.79 - $8.20
Previous Close$0.82
Volume2.37M
Average Volume (3M)1.60M
Market Cap
$49.95M
Enterprise Value-$3.51M
Total Cash (Recent Filing)$63.60M
Total Debt (Recent Filing)$10.14M
Price to Earnings (P/E)-0.1
Beta2.74
Next Earnings
May 09, 2024EPS Estimate
-$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.64
Shares Outstanding54,694,000
10 Day Avg. Volume1,994,267
30 Day Avg. Volume1,602,185
Standard Deviation0.80
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.75
Price to Sales (P/S)5.43
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.10
Enterprise Value/Gross Profit-0.59
Enterprise Value/Ebitda0.02
Forecast
1Y Price Target
$7.67Price Target Upside874.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
BioNano Genomics News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company has implemented a number of cost savings initiatives, resulting in reduced operational expenses.
Product LaunchBionano announced the formal launch of its next-gen Stratys system, which can drive a 4-fold increase in throughput and can process up to 12 single access chips at the same time, at a reduced turnaround time.
Technology AdvancementUtility in brain cancer: OGM led to a ~20% increase in the detection of pathogenic variants in brain cancer that were previously not identified using legacy techniques.
Bears Say
Financial OutlookDespite a positive view on Saphyr technology, capital needs remain an ongoing concern, leading to a downgrade of BNGO shares to Hold.
Potential DilutionThe company may need to leverage its ATM, adding substantial dilution given the low share price.
Stock PerformanceSince the financing, BNGO shares have declined by approximately 50% to $1.30, well below the conversion price of $2.86.
---
Ownership Overview
9.73% Insiders
3.29% Mutual Funds
3.09% Other Institutional Investors
83.90% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNGO FAQ
What was BioNano Genomics Inc’s price range in the past 12 months?
BioNano Genomics Inc lowest stock price was $0.79 and its highest was $8.20 in the past 12 months.
What is BioNano Genomics Inc’s market cap?
Currently, no data Available
When is BioNano Genomics Inc’s upcoming earnings report date?
BioNano Genomics Inc’s upcoming earnings report date is May 09, 2024 which is in 20 days.
How were BioNano Genomics Inc’s earnings last quarter?
BioNano Genomics Inc released its earnings results on Mar 05, 2024. The company reported -$1.115 earnings per share for the quarter, missing the consensus estimate of -$0.871 by -$0.244.
Is BioNano Genomics Inc overvalued?
According to Wall Street analysts BioNano Genomics Inc’s price is currently Undervalued.
Does BioNano Genomics Inc pay dividends?
BioNano Genomics Inc does not currently pay dividends.
What is BioNano Genomics Inc’s EPS estimate?
BioNano Genomics Inc’s EPS estimate is -$0.65.
How many shares outstanding does BioNano Genomics Inc have?
BioNano Genomics Inc has 61,230,682 shares outstanding.
What happened to BioNano Genomics Inc’s price movement after its last earnings report?
BioNano Genomics Inc reported an EPS of -$1.115 in its last earnings report, missing expectations of -$0.871. Following the earnings report the stock price went up 1.681%.
Which hedge fund is a major shareholder of BioNano Genomics Inc?
Among the largest hedge funds holding BioNano Genomics Inc’s share is GMT Capital Corp. It holds BioNano Genomics Inc’s shares valued at 1M.
---
BioNano Genomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.67 (874.34% Upside)
$7.67 (874.34% Upside)
Blogger Sentiment
Neutral
BNGO Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 6.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 6.7%
Last 30 Days ▼ 6.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.90%
12-Months-Change
Fundamentals
Return on Equity
-134.56%
Trailing 12-Months
Asset Growth
-30.28%
Trailing 12-Months
Company Description
BioNano Genomics Inc
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
---
BNGO Earnings Call
Q4 2024
0:00 / 0:00
---
BNGO Stock 12 Months Forecast
Average Price Target
$7.67
▲(874.34% Upside)
Technical Analysis
Best Analysts Covering BNGO
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-60.29%
reiterated a buy rating 3 months ago
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.29% per trade.
---